Royal Philips/$PHG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Royal Philips
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
Ticker
$PHG
Sector
Primary listing
NYSE
Employees
67,263
Headquarters
Website
Royal Philips Metrics
BasicAdvanced
$26B
133.90
$0.20
0.84
$0.82
3.03%
Price and volume
Market cap
$26B
Beta
0.84
52-week high
$31.55
52-week low
$20.77
Average daily volume
608K
Dividend rate
$0.82
Financial strength
Current ratio
1.259
Quick ratio
0.715
Long term debt to equity
69.005
Total debt to equity
80.957
Dividend payout ratio (TTM)
182.10%
Interest coverage (TTM)
3.58%
Profitability
EBITDA (TTM)
1,879.31
Gross margin (TTM)
43.84%
Net profit margin (TTM)
0.91%
Operating margin (TTM)
5.92%
Effective tax rate (TTM)
79.10%
Revenue per employee (TTM)
$313,790
Management effectiveness
Return on assets (TTM)
2.37%
Return on equity (TTM)
1.50%
Valuation
Price to earnings (TTM)
133.903
Price to revenue (TTM)
1.215
Price to book
2.13
Price to tangible book (TTM)
-13.03
Price to free cash flow (TTM)
49.982
Free cash flow yield (TTM)
2.00%
Free cash flow per share (TTM)
0.543
Dividend yield (TTM)
3.03%
Forward dividend yield
3.03%
Growth
Revenue change (TTM)
-1.53%
Earnings per share change (TTM)
-139.37%
3-year revenue growth (CAGR)
1.27%
10-year revenue growth (CAGR)
-2.52%
3-year earnings per share growth (CAGR)
-61.88%
10-year earnings per share growth (CAGR)
-8.07%
3-year dividend per share growth (CAGR)
1.75%
10-year dividend per share growth (CAGR)
1.34%
What the Analysts think about Royal Philips
Analyst ratings (Buy, Hold, Sell) for Royal Philips stock.
Bulls say / Bears say
In Q2 2025, Philips grew comparable order intake by 6% and comparable sales by 1%, while expanding its adjusted EBITA margin by 130 basis points to 12.4%, enabling management to raise full-year margin and free cash flow targets (Reuters)
Following a US-EU tariff deal, Philips trimmed its anticipated tariff hit to €150–€200 million and lifted its full-year adjusted EBITA margin guidance to 11.3%–11.8%, demonstrating effective cost mitigation and resilience to trade pressures (Reuters)
Philips reported that its 6% order intake growth in Q2 was driven by AI-powered diagnostic systems and concurrently secured a long-term agreement with Indonesia’s Ministry of Health to deploy Azurion image-guided therapy nationwide, underscoring its innovation-led growth strategy (Reuters)
Philips faces a French criminal investigation into its 2021 global sleep apnea device recall, with Paris prosecutors probing potential charges of aggravated fraud that could result in fines up to €3.75 million and add to the company’s legal overhang (Reuters)
In May 2025, Philips cut its full-year adjusted EBITA margin forecast to 10.8%–11.3% due to an expected €250–€300 million net impact from US-China tariffs, sending its shares down as much as 4% and highlighting vulnerability to trade headwinds (Reuters)
As part of its tariff mitigation plan, Philips indicated it may implement additional job cuts under its broader savings program to offset the €250–€300 million cost impact, raising execution risk and potential workforce disruptions (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 3 Oct 2025.
Royal Philips Financial Performance
Revenues and expenses
Royal Philips Earnings Performance
Company profitability
Royal Philips News
AllArticlesVideos
Philips in talks with US over probes of medical technology imports
Reuters3 weeks ago
Investor association VEB calls for court inquiry into Philips sleep apnea recall
Reuters3 weeks ago
Philips, Philips Foundation, and MedShare Launch Program to Strengthen U.S. Healthcare Readiness for Natural Disasters
Business Wire1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Royal Philips stock?
Royal Philips (PHG) has a market cap of $26B as of October 15, 2025.
What is the P/E ratio for Royal Philips stock?
The price to earnings (P/E) ratio for Royal Philips (PHG) stock is 133.9 as of October 15, 2025.
Does Royal Philips stock pay dividends?
Yes, the Royal Philips (PHG) stock pays dividends to shareholders. As of October 15, 2025, the dividend rate is $0.8222 and the yield is 3.03%. Royal Philips has a payout ratio of 182.1% on a trailing twelve-month basis.
When is the next Royal Philips dividend payment date?
The next Royal Philips (PHG) dividend payment date is unconfirmed.
What is the beta indicator for Royal Philips?
Royal Philips (PHG) has a beta rating of 0.84. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.